Lennox-Gastaut syndrome (LGS) is a severe form of childhood epilepsy defined by multiple seizure types that are difficult to control, distinctive brain wave patterns on an EEG, and cognitive difficulties that often worsen over time. It accounts for roughly 4 to 8% of all childhood epilepsy cases, with onset typically between ages 3 and 5. LGS is considered one of the most challenging epilepsy syndromes to treat, and it persists into adulthood for most people who have it.
What Makes LGS Different From Other Epilepsies
Most forms of epilepsy involve one type of seizure. LGS involves several. The combination of multiple, drug-resistant seizure types is one of its defining features, along with a specific slow electrical pattern on brain wave testing and some degree of cognitive impairment. All three elements need to be present for a diagnosis.
The seizure types most closely associated with LGS include tonic seizures (where the muscles suddenly stiffen, often during sleep), atonic seizures (where muscle tone drops abruptly, causing “drop attacks” that send a person to the ground), and atypical absence seizures (brief episodes of staring or reduced awareness that start and end less sharply than typical absence seizures). Many people with LGS also experience tonic-clonic seizures and myoclonic jerks. A single person may have several of these types in a single day.
Drop attacks are especially dangerous because they happen without warning. A child or adult simply collapses, often striking their head or face. This makes protective helmets a practical necessity for many people with LGS, and fall-related injuries are a major ongoing concern.
How LGS Is Diagnosed
Diagnosis relies heavily on EEG findings. Two specific brain wave patterns must be present. The first is a generalized slow spike-and-wave pattern at a frequency of 2.5 Hz or less, most prominent over the frontal region of the brain. Normal spike-and-wave patterns in other epilepsies run faster, around 3 Hz or above, so this slower rhythm is a red flag. The second is something called paroxysmal fast activity: brief bursts of rapid electrical activity (10 to 30 Hz) that typically appear during sleep.
These EEG findings, combined with multiple seizure types and evidence of cognitive problems, form the mandatory diagnostic criteria. Because LGS often evolves from other childhood epilepsy conditions, including infantile spasms (West syndrome), doctors sometimes rely on prior EEG recordings alongside current ones to confirm the diagnosis.
What Causes It
In many cases, LGS has an identifiable cause. Structural brain abnormalities present from birth, brain injuries from oxygen deprivation during birth, severe infections like meningitis or encephalitis, and genetic conditions such as tuberous sclerosis can all lead to LGS. Some children develop it after a history of infantile spasms that prove difficult to control.
In a smaller number of cases, no clear cause is found despite thorough testing. These are sometimes called cryptogenic cases. Regardless of the underlying cause, the syndrome tends to follow a similar pattern: seizures that resist treatment and cognitive development that plateaus or declines over time.
Cognitive and Behavioral Effects
Intellectual disability is nearly universal in LGS, though its severity varies. A study of 38 adults who had been diagnosed with LGS in childhood found that about 24% had mild intellectual disability, another 24% had moderate disability, and roughly 53% had severe disability. Every participant in that study scored low on measures of adaptive behavior, the practical skills needed for daily living like communication, self-care, and social interaction.
Behavioral and psychiatric challenges are also common. In the same study, nearly two-thirds of patients had some form of behavioral or psychiatric comorbidity, and about one in five needed medication to manage psychiatric symptoms. These difficulties tend to compound over time, partly because ongoing seizure activity disrupts brain development and partly because the medications used to control seizures can affect cognition and mood.
Treatment Options
LGS is notoriously resistant to medication. Most people require multiple drugs, and even then, complete seizure freedom is rare. The goal is usually to reduce how often seizures happen, especially the most dangerous types like drop attacks.
Seven medications are specifically approved for seizures associated with LGS: clobazam, rufinamide, topiramate, lamotrigine, felbamate, clonazepam, and cannabidiol (a purified, pharmaceutical-grade form approved for patients 2 years and older). Each of these works through a different mechanism, and treatment plans are often adjusted frequently as seizure patterns change. Many people with LGS cycle through several medications or combinations before finding a regimen that helps.
Surgical and Device-Based Options
When medications alone aren’t enough, two non-drug approaches are commonly considered. Vagus nerve stimulation (VNS) involves a small device implanted under the skin of the chest that sends regular electrical pulses to the brain through a nerve in the neck. A large study across six centers found that VNS reduced total seizures by a median of about 58% after three to six months. Roughly 20% of patients in one study became seizure-free at 12 months after implantation.
Corpus callosotomy is a surgical procedure that cuts the band of nerve fibers connecting the two halves of the brain. It’s particularly effective against drop attacks. One study reported that 85% of patients who underwent total corpus callosotomy experienced either complete cessation of drop attacks or a 90% reduction, with results holding over follow-up periods of at least 40 months. Another study found that about 78% of patients with drop attacks achieved excellent outcomes after the procedure. The surgery doesn’t cure LGS, but it can dramatically reduce the seizure type most likely to cause serious injury.
The ketogenic diet, a high-fat, very low-carbohydrate eating plan supervised by a medical team, is another option some families pursue. It requires strict adherence but can meaningfully reduce seizure frequency in some children with drug-resistant epilepsy.
Living With LGS Long-Term
LGS is a lifelong condition for the vast majority of people diagnosed with it. Seizures typically persist into adulthood, though their patterns may shift over time. The tonic seizures of childhood sometimes become less frequent, while other seizure types may emerge or worsen. Most adults with LGS continue to require daily medication and ongoing medical care.
The practical reality of living with LGS centers on safety and support. Drop attacks make protective headgear important for many people, especially children, to prevent head injuries from sudden falls. Environmental modifications at home, like padded flooring and avoiding sharp-edged furniture, can reduce injury risk. Because of the cognitive and behavioral effects of the syndrome, most adults with LGS need some level of assistance with daily living, and many require full-time care.
For families navigating this diagnosis, the picture can feel overwhelming. But the range of treatment options has expanded meaningfully in recent years, and newer therapies like pharmaceutical cannabidiol have added tools that didn’t exist a decade ago. The focus of care is on minimizing seizure burden, protecting against injury, and supporting the best possible quality of life at each stage.